Ketryx, the agentic continuous compliance platform for safety-critical product development, announced today that William A. Hawkins, former Chairman and CEO of Medtronic, has joined its Board of Directors and participated in the company’s Series B financing. The move underscores the growing importance of AI in streamlining regulatory compliance for medical devices, pharmaceuticals, and robotics.
Hawkins, who led Medtronic from 2007 to 2011 and oversaw its expansion into new markets, brings decades of experience in navigating complex regulatory environments. His appointment signals Ketryx's ambition to solve what the company calls the "AI bottleneck" in life sciences—the challenge of integrating AI tools while maintaining compliance with stringent safety standards.
Ketryx's platform addresses this by automatically generating compliant documentation, maintaining continuous traceability, and enabling safe and verifiable AI at scale within the tools teams already use. According to the company, its AI Agents reduce manual work by up to 90 percent and help identify and close compliance gaps, improving both speed and quality across the product lifecycle.
The platform is already trusted by four of the world's top five medical device manufacturers. By overlaying existing tools, Ketryx allows teams to accelerate release cycles without disrupting established workflows, a critical factor for companies that must adhere to FDA and other regulatory requirements.
For leaders in business and technology, this development highlights a broader trend: the convergence of AI and regulatory compliance is becoming a strategic priority. As AI adoption accelerates in safety-critical industries, the ability to demonstrate compliance efficiently can be a competitive differentiator. Hawkins' involvement suggests that Ketryx's approach has strong industry backing and could set a new standard for how life sciences companies manage product development.
The implications extend beyond medical devices. Pharmaceutical companies and robotics firms face similar challenges in documenting and tracing changes throughout the product lifecycle. Ketryx's platform offers a way to automate these processes, potentially reducing time-to-market and lowering costs.
For more information about Ketryx and its platform, visit www.ketryx.com.
